Sarepta's Elevidys approval, revenue growth projections, and competitive position make it a strong investment in DMD ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

Merck MRK announced that a phase study evaluating its Daiichi Sankyo-partnered HER3-directed DXd antibody drug conjugate (ADC ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...

Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

After underperforming over the past few years, these stocks offer huge dividend yields that could keep rising throughout your ...

Having already scooped up the U.S. rights to Capricor Therapeutics’ late-stage Duchenne muscular dystrophy (DMD) therapy, ...

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...